Key result
CIED implantation carries up to ~20% mortality when complicated by endocarditis or sepsis.
Why the study?
Cardiac implantable electronic device infections often feature systemic inflammation without early signs of heart damage, leading to delayed diagnosis, tricuspid valve involvement, and poor prognosis.
Case Report (n=2)
Answers are grounded in this paper and cite their sources.
Illustrates the diagnostic and treatment difficulties of late electrode sepsis following cardiac implantable electronic device implantation, which is characterized by predominant systemic inflammation and delayed signs of cardiac damage.
Modern cardiology is impossible without implantation of intracardiac devices, such as cardiac pacemakers, resynchronization therapy devices, implantable cardioverter-defibrillators. Meanwhile, as the number of implanted devices increases, so does the number of cases of their infection [1]. At present, sufficient clinical material has been accumulated, demonstrating the obvious features of the course of this type of IE, leading to late diagnosis, the spread of infection to the tricuspid valve and, as a result, to a poor prognosis. The frequency of purulent complications after implantation of pacemakers is from 0.6 to 5.7%; mortality rate varies from 0.13% in local purulent inflammation to 19.9% in bacterial endocarditis and sepsis [2]. Abroad, term electrode sepsis is widely used to reflect the main features of the course of cardiac implantable electronic device infection, which are the predominance of systemic inflammation symptoms and the long-term absence of heart damage signs. We present two typical cases of the course of cardiac implantable electronic device infection, illustrating the difficulties of diagnosing and treating this disease.
No takes yet. Share an insight, caveat, or question.
Zimina et al. (2021) conducted a case report in Cardiac implantable electronic device infection (late electrode sepsis) (n=2). Cardiac implantable electronic device (pacemaker, resynchronization therapy device, or ICD) was evaluated. Cardiac implantable electronic device implantation is associated with a 0.6% to 5.7% frequency of purulent complications and up to 19.9% mortality in endocarditis and sepsis.
Synapse has enriched 10 related papers. Consider them for comparative context: